Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Several possible studies

Story checked

AtlasPlex™ brings custom 5-plex IHC on FFPE tissue into a single day (opens in a new tab)

news-medical.net · 2026-09-30

Short answerEvidenceSource

Short answer

Several possible studies

No clear answer.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Several studies could be the source of this story.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Open claim evidence
3

Search result

Several studies could fit.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Related research

Research nearby

The papers it could be

Nearby papers when the source is unclear.

and 15 more considered

Then inspect each claim

Evidence layer

Claim by claim

What the story asserts. With no source study, there is nothing to check these against.

Claim 1 of 5Not checkedAtlas Antibodies has launched AtlasPlex™, a new ready-to-use multiplex immunohistochemistry kit.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 2 of 5Not checkedThe kit lets researchers build their own 3- or 5-plex panels from more than 17,000 IHC-validated antibodies covering over 12,000 human genes.View evidenceHide evidence

As stated3- or 5-plex panels; more than 17,000 antibodies; over 12,000 human genes

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 3 of 5Not checkedAtlasPlex is described as removing secondary antibodies, species restrictions, and harsh stripping steps by using pre-biotinylated, pre-complexed HRP antibodies with tyramide signal amplification.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 4 of 5Not checkedThe company says the method provides a strong, permanent fluorescent signal and can be used to stain up to five markers in one day, with each cycle taking about 1.5 hours.View evidenceHide evidence

As statedup to five markers in one day; each cycle about 1.5 hours

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 5 of 5Not checkedThe article says the kit is intended for flexible multiplex staining on FFPE tissue for applications such as spatial biology, tumor microenvironment studies, and biomarker discovery.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Finally, the search trail

Method layer

No single source study was found.

NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.

Nearby research

No exact source, but these papers are close.

PubMed, Crossref, Europe PMC · 15 candidate papers

CandidateOpen access

Research progress and perspectives on the application of tyramide signal amplification-based multiplex immunohistochemistry/immunofluorescence: a bibliometrics analysis.

Frontiers in Oncology · 2024 · PubMed, Europe PMC, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)

And 10 more candidates considered.